TipRanks
Go Ultimate55% OFF

Lifeist Wellness (LFST) AI Stock Analysis

TSE:LFST

Lifeist Wellness

(TSXV:LFST)

Select Model
Rating:44Neutral
Price Target:CAD 0.03â–¼(-2.86% Downside)
Action:reiterated
Date:10/28/26

The score is weighed down primarily by very weak financial performance (collapsed revenue, negative gross profit and operating margins, and ongoing cash burn despite no debt). Technicals add pressure with a bearish moving-average setup and negative MACD. Valuation is a modest positive (low P/E), but it is not enough to offset the operational and cash-flow risks.

Positive Factors
Debt-Free Balance SheetZero reported debt reduces fixed financial obligations and interest-related pressure, giving Lifeist greater flexibility than a similarly weak but leveraged company. This provides some capacity to restructure operations or allocate resources toward recovery without immediate lender constraints.
Negative Factors
Severe Revenue ContractionThe collapse in revenue indicates a substantial deterioration in commercial scale and materially weakens the platform available to support fixed costs, product investment, and distribution. Unless sustained growth returns, the much smaller revenue base makes a durable recovery in earnings and cash generation difficult.

Lifeist Wellness (LFST) vs. iShares MSCI Canada ETF (EWC)

-50%-40%-30%-20%-10%0%10%20%30%TSE:LFST-41.67%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
CAD 1.33M
Dividend Yield
―
Average Volume (3M)
34.43K
Price to Earnings (P/E)
8.3
Beta (1Y)
0.83
Revenue Growth
-87.74%
EPS Growth
-220.61%
Country
Canada
Employees
72
Sector
Consumer Defensive
Sector Strength
62
Industry
Medical - Pharmaceuticals

Lifeist Wellness Business Overview & Revenue Model

Company Description

Headquartered in Vancouver, Canada, and established in 2005, Lifeist Wellness Inc. (formerly Namaste Technologies Inc. until September 2021) operates as a multifaceted wellness enterprise across the United States and Canada. Its diverse portfolio inc...

How the Company Makes Money

Lifeist generates revenue primarily through sales made by its operating subsidiaries. Key revenue streams have historically included (1) consumer wellness product sales (e.g., plant-based/alternative wellness products sold through wholesale, retail,...

Lifeist Wellness Financial Statement Overview

Summary

Financials are very weak overall: revenue has collapsed to roughly ~$0.25–0.28M versus ~$21–22M historically, gross margin is negative, and operating/EBITDA margins are deeply negative. Cash flow remains a major concern with persistent negative operating cash flow and TTM free cash flow around -$1.56M, indicating ongoing funding needs. The main offset is no reported debt and a slight TTM net income improvement, but this is not supported by operations and equity has eroded sharply.

Income Statement

18Very Negative

Balance Sheet

42Neutral

Cash Flow

12Very Negative
Financial statement breakdown
BreakdownTTMFeb 2026Feb 2025Feb 2024Feb 2023Feb 2022
Income Statement
Total Revenue281.14K249.37K588.80K21.66M22.07M21.15M
Gross Profit-321.93K-845.37K204.75K5.34M3.79M120.29K
EBITDA-1.60M-2.39M-3.99M-5.96M-17.44M-20.25M
Net Income3,858-2.99M-1.45M-14.13M-15.44M-23.80M
Balance Sheet
Total Assets1.14M1.84M5.13M13.40M20.67M37.96M
Cash, Cash Equivalents and Short-Term Investments74.15K781.81K2.34M1.45M3.80M12.74M
Total Debt0001.27M328.33K554.59K
Total Liabilities408.67K688.62K1.06M9.94M7.30M11.89M
Stockholders Equity730.50K1.15M4.07M3.46M13.36M26.06M
Cash Flow
Free Cash Flow-1.56M-2.90M-877.20K-2.79M-16.04M-18.64M
Operating Cash Flow-1.56M-2.90M-877.20K-2.46M-15.35M-18.28M
Investing Cash Flow665.12K1.34M1.92M1,2776.69M-229.57K
Financing Cash Flow00-169.19K83.82K-252.29K21.02M

Lifeist Wellness Technical Analysis

Technical Analysis SentimentNegative
Last Price0.04

Price Trends

50DMA0.05Negative
100DMA0.05Negative
200DMA0.05Negative

Market Momentum

MACD-0.00Positive
RSI36.32Neutral
STOCH-0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LFST, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.05, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 36.32 is Neutral, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LFST.

Lifeist Wellness Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

TSE:LFST against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TSE:LFSTTSE:LFST44NeutralCAD 1.33M8.330.38%―-87.74%-220.61%
TSE:MGWTSE:MGW21UnderperformCAD 969.81K-1.327.55%――-141.90%

* Consumer Defensive Sector Average

Performance Comparison

-40%-20%0%TSE:LFSTTSE:MGWTSE:TCANTSE:SILODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
TSE:LFST and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:LFSTLifeist Wellness Inc0.04-0.04-50.00%
TSE:MGWMaple Leaf Green World0.030.000.00%
TSE:TCANTranscanna Holdings0.010.000.00%
TSE:SILOSilo Wellness Inc0.010.000.00%

Lifeist Wellness Corporate Events

Business Operations and StrategyRegulatory Filings and Compliance

Lifeist Wellness Adopts Semi-Annual Reporting Under Venture Issuer Exemption

Neutral
Oct 14, 2026

Lifeist Wellness Inc. has opted to move to a semi-annual financial reporting schedule under a Canadian coordinated blanket order that permits certain venture issuers to reduce the frequency of their interim filings. With a fiscal year ending November...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026